SPECTRAL AI, INC. Deferred Offering Costs
SPECTRAL AI, INC. (MDAI) had Deferred Offering Costs of $283.00 thousand as of 2023-12-31, per its 10-Q filed 2024-11-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:DeferredOfferingCosts · last filed 2024-11-06
- 2023-12-31: Deferred Offering Costs $283.00K.
- 2023-06-30: Deferred Offering Costs $1.12M; Deferred Offering Costs as first filed $458.13K.
- 2023-03-31: Deferred Offering Costs $458.13K.
- 2022-09-30: Deferred Offering Costs $458.13K.
| Period end | Deferred Offering Costs | Deferred Offering Costs as first filed |
|---|---|---|
| 2023-12-31 | $283.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $1.12M 8-K · filed 2023-09-15 | $458.13K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $458.13K 10-Q · filed 2023-05-12 | |
| 2022-09-30 | $458.13K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $458.13K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $458.13K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $458.13K 10-K · filed 2022-03-31 | |
| 2021-09-30 | $458.13K 10-Q · filed 2021-11-22 | |
| 2021-06-30 | $458.13K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $458.13K 10-Q · filed 2021-06-14 | |
| 2021-02-17 | $14.37M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |